Amal Ltd Overview
Amal Ltd is a small, debt-free maker of sulphur-based bulk chemicals controlled by Atul Ltd, one of India's largest integrated chemical companies. Its main job is backward integration for Atul. Its plants at Ankleshwar, Gujarat sit next to Atul's aromatics complex and have a combined 440 tonnes per day (TPD) of sulphuric-acid-equivalent capacity: 140 TPD in Amal itself and 300 TPD in its wholly owned subsidiary ASCL. They produce sulphuric acid, oleum, sulphur dioxide and sulphur trioxide, and sell by-product steam. About 38% of consolidated revenue comes from Atul. The rest goes to merchant customers in dyestuffs, pharmaceuticals, petrochemicals, textiles and personal care. Economics are driven almost entirely by the spread between product prices and the cost of sulphur, which is about 85% of costs. As a result, revenue swings with sulphur prices more than with volumes. Parent support, full capacity utilisation and a net-cash balance sheet make Amal a high-quality but structurally small, single-product, captive-anchored business.
What the company does. Amal makes bulk chemicals by burning sulphur. Elemental sulphur is burned to make sulphur dioxide (SO2), which is converted catalytically to sulphur trioxide (SO3) and absorbed to give sulphuric acid (H2SO4, mainly 98%) and oleum (fuming sulphuric acid). Liquid SO2 and SO3 are also sold as downstream products in their own right. The process is strongly exothermic, so the plants recover heat as steam. Since June 2023 steam has been sold to Atul and is now a meaningful revenue line, at about 16% of FY2026 revenue according to CARE, which puts sulphur-based products at about 84%.
Company's own description. Amal's annual reports (FY2015-16 through FY2025-26) describe the company as engaged in manufacturing and marketing bulk chemicals such as sulphuric acid and oleum and their downstream products such as sulphur dioxide and sulphur trioxide, with its plant at Ankleshwar, Gujarat. IIFL's summary of company disclosures adds that these chemicals are used in dyestuff, fertiliser, personal care, petrochemical, pharmaceutical and textile industries.
Business model and revenue model.
Independent characterisation. Amal is best understood as a captive utility for Atul that also sells into the merchant market. Atul built the ASCL facility to secure consistent, quality sulphuric acid supply, protect itself against volatile market prices and save freight (CARE). The arrangement gives Amal low sales risk and full utilisation, as CARE says it ran at full capacity in FY2025-FY2026. The trade-off is limited pricing power and exposure to sulphur price spikes that cannot be fully passed through. The steam business is a structural positive: it turns waste heat into revenue with almost no extra cost and ties Amal more closely into Atul's energy system. It also has no direct exposure to commodity-acid price cycles.
Strategy
Stated strategic themes (from annual reports, CARE and board disclosures).
-
Backward integration for Atul. Amal's operations serve as backward integration for Atul. Plants located near Atul's aromatics division supply sulphuric acid and derivatives at low freight cost (CARE). Atul set up the ASCL facility to secure consistent quality supply, protect against acid-price volatility and save freight.
-
Full use of the asset base and by-products. The company ran at full utilisation in FY2025–FY2026 and is monetising steam.
-
Debottlenecking downstream products. The SO2 capacity increase is described by the company as part of its strategic growth plan.
-
Balance-sheet conservatism. It is debt-free, with internal funding of capex (CARE).
-
Team values. Annual reports refer to "five everlasting mandates" of team Amal (AR FY2020-21). The diya logo stands for ethics, hard work and purpose (AR FY2018-19).
Initiatives announced in the last 24 months.
Medium-term financial targets / guidance: not publicly disclosed. Amal holds no earnings calls or investor days.
ESG commitments: Amal has made no specific emissions targets public. It sits within the Atul group's CSR programme through Atul Foundation.
Products & Services
All products fall within the single "bulk chemicals" segment and are made at Ankleshwar, Gujarat. Amal does not market products under consumer brands, and price lists are not disclosed.
Historical products (discontinued). Pigments (1,200 tpa), H-Acid and other dye intermediates, and a bulk-drug project were part of the pre-BIFR portfolio (IIFL). None appear in current disclosures.
Flagship offering. The ASCL 300 TPD sulphuric acid plant and its steam stream are the group's flagship asset.
Product Portfolio
| Product | Description and specification | Main applications and target customers | Producing entity and capacity | Launch / latest expansion | Pricing model |
|---|---|---|---|---|---|
Sulphuric acid (H2SO4), mainly 98% | Commodity mineral acid made by the contact process from burnt sulphur | Atul's aromatics and intermediates plants; dyestuffs, pharma, textiles, petrochemicals, fertilisers | Amal 140 TPD + ASCL 300 TPD = 440 TPD (sulphuric acid equivalent) | Amal plant operational FY2008-09 and expanded FY2011-12; ASCL commissioned FY2023 | Merchant/contract pricing linked to sulphur costs. Supply to Atul is arm's-length related-party sales; contract terms not disclosed. |
Oleum (fuming sulphuric acid; grades not disclosed) | H2SO4 with dissolved SO3; a strong sulphonating agent | Dye intermediates, sulphonation chemistry, explosives and pharma intermediates | Shared capacity within the 440 TPD | Oleum project implemented historically (undated) | — |
Sulphur dioxide (SO2), liquid | Liquefied SO2 drawn from the burner stage | Bleaching, food and pharma processing, sulphite chemistry, water treatment, chemical synthesis | Amal: 45 TPD, being raised to 105 TPD (₹12 cr capex approved 17 Jul 2026; about two years to complete) | Plant set up FY2011-12 | — |
Sulphur trioxide (SO3), liquid | Stabilised liquid SO3 | Sulphonation for detergents (LABSA) and personal care surfactants, dyes | Capacity not separately disclosed | Plant set up FY2011-12 | — |
Steam (utility) | By-product steam from exothermic sulphur combustion, recovered through waste-heat boilers | Atul's Ankleshwar complex | Volume not disclosed. A steam pipeline is in the ~₹25 cr capex programme to improve steam utilisation (CARE). | Steam sales to Atul began June 2023 | Not disclosed; about 16% of FY2026 revenue |
“—” = not publicly disclosed.
Financial Narrative
All figures are consolidated, ₹ crore, fiscal years ending 31 March. FY2022–FY2024 are from Screener (rounded). FY2025–FY2026 are from the Directors' Report FY2025-26 and CARE Oct 2026, supplemented by quarterly sums from Screener.
Income statement
Notes. Gross profit is not reported, because Indian Ind AS statements are presented by nature of expense. Simply Wall St's trailing-twelve-month (TTM) data imply gross profit of about ₹58 cr on ₹290 cr revenue. Diluted EPS equals basic because there are no dilutive instruments. FY2025 other income, depreciation and interest are sums of Screener quarterly data. FY2026 depreciation (₹9.31 cr) and finance cost (₹0.65 cr) are from Fyers' summary of FY2026 accounts.
Margins and growth
Revenue CAGR: FY2022–FY2026 (4-year) about 53.7% (computed). FY2021–FY2026 (5-year) about 51.6%, against Screener's 51%. Profit CAGR over 5 years is about 21% (Screener).
Quarterly trajectory (last six quarters)
Source: Screener consolidated quarterly table. Q1 FY2027 other income includes a one-time recognition of ₹5.61 cr of government incentives for ASCL (FilingReader summary of the 17 Jul 2026 filing). Q2 FY2027 standalone profit was ₹4.01 cr (BSE outcome, 16 Oct 2026).
H1 FY2027 compared with H1 FY2026: revenue ₹227.8 cr vs ₹101.3 cr (+125%); net profit ₹22.9 cr vs ₹15.5 cr (+48%). TTM to Sep 2026: revenue ₹366 cr, net profit about ₹30 cr, EPS ₹24.11 (Screener).
Balance sheet
Notes:
-
Equity per CARE is ₹99.0 cr for FY2025 and ₹120.4 cr for FY2026.
-
The short-term versus long-term debt split is not disclosed in the sources reviewed. CARE confirms nil fund-based borrowings at 31 Mar 2026 and no scheduled debt obligations in FY2027.
-
Goodwill and intangibles: none disclosed; no acquisitions have been made.
-
Cash and equivalents are not separately reported in the Screener summary. CARE reports ₹30.7 cr at 30 Jun 2026.
-
Equity at 30 Sep 2026 was about ₹141 cr, total assets about ₹195 cr, and borrowings nil (Screener half-year balance sheet).
-
Book value per share was ₹114 in Sep 2026.
Net debt:
-
FY2022–FY2024: positive. Gross debt was ₹51 cr, ₹35 cr and ₹24 cr, against cash that is not separately disclosed.
-
FY2025–FY2026: net cash. Debt is nil, with ₹20 cr and ₹37 cr of investments.
Working capital: CARE reports a current ratio of 1.89x at 31 Mar 2025 and 2.48x at 31 Mar 2026. Screener working-capital days moved from -11 in FY2025 to +7 in FY2026.
Cash flow
Source: Screener. Capex is derived as CFO minus FCF. Dividend paid in FY2026 is derived from the ₹1 per share FY2025 dividend on 12.36 million shares. The FY2023 financing inflow includes the ₹49.94 cr rights issue, net of ₹36 cr debt repayment. CARE reports gross cash accruals of ₹35.0 cr in FY2026.
Ratios
Notes:
-
FY2025 and FY2026 interest coverage are CARE figures (21.53x, 54.57x). Earlier years are computed from rounded Screener data.
-
ROIC is not separately computed; ROCE is shown as the proxy.
-
Net debt/EBITDA is not meaningful. In FY2025–FY2026 the company had net cash. In FY2022 gross debt/EBITDA was about 12.8x. In FY2023 EBITDA was negative. In FY2024 gross debt/EBITDA was about 1.6x.
-
ROE and ROA use average balances. The FY2021 opening values are equity ₹34 cr and assets ₹48 cr.
Commentary on trends, inflections and drivers
FY2022–FY2023: the investment trough. ASCL's construction pushed capex to about ₹63 cr in FY2022, with ₹66 cr in CWIP at year-end, funded mainly by borrowings that reached ₹51 cr and a debt/equity of 1.46x. In FY2023 the new plant was commissioned but could not run fully (AR FY2022-23). Depreciation rose to about ₹7 cr and interest to about ₹4 cr, producing a ₹16 cr net loss. The ₹49.94 cr rights issue in March 2023 repaired the balance sheet and cut debt by ₹36 cr.
FY2024: stabilisation. Capacity utilisation improved after ASCL stabilised (CARE Oct 2024). Steam sales to Atul from June 2023 added a high-margin stream. EBITDA margin recovered to about 17%. Profit stayed thin at about ₹2 cr because depreciation and interest absorbed most of the EBITDA.
FY2025: the peak-margin year. Revenue grew 57% to ₹135 cr and EBITDA margin reached 32.3%. Volume, steam and a still-moderate average sulphur cost all contributed; CARE puts sulphur at US$157/MT on average in FY2025 against US$107/MT in FY2024. Net profit of ₹29.3 cr was a record, consistent with Atul's statement that Amal and ASCL recorded their highest sales and PBT so far. The company became debt-free.
FY2026: revenue up, margins down. Revenue rose 77% to ₹240 cr. Per CARE, average realisation rose about 93% while volumes rose only about 5%, because average sulphur prices nearly tripled to US$418/MT. Pass-through was incomplete, so EBITDA fell to ₹35.7 cr and margin to 14.9%. Q4 FY2026 was the low point, with a 9.7% margin and a 66% tax rate that cut PAT to ₹1.9 cr.
FY2027 so far: volatility. In Q1, inventory-led gains (CARE) and a ₹5.61 cr one-off incentive lifted PBT to ₹20.9 cr, despite a planned maintenance shutdown that cut volumes by about 15%. In Q2, revenue reached ₹131 cr but margin collapsed to 6.45%, because sulphur rose to about US$1,050/MT on West Asia conflict and supply disruption (CARE Oct 2026). The market reacted with a 20% share-price fall on 16 Oct 2026.
Balance-sheet quality. Despite margin compression, the balance sheet keeps strengthening. Equity grew from ₹99 cr to ₹141 cr between Mar 2025 and Sep 2026, debt is zero and investments are ₹37 cr. Working capital has moved from negative to modestly positive as receivables grow with higher prices.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Activity | Capacity |
|---|---|---|---|
Amal Ltd (standalone) | Listed parent | Sulphuric acid, oleum, SO2, SO3 at Ankleshwar | 140 TPD sulphuric acid; 45 TPD SO2 (expanding to 105 TPD) |
Amal Speciality Chemicals Ltd (ASCL) | 100% subsidiary; material subsidiary | Sulphuric acid 98% and derivatives; steam to Atul | 300 TPD sulphuric acid equivalent |
Atul Ltd | Ultimate controlling shareholder (49.86% via Atul Finserv Ltd); Amal is a subsidiary of Atul through control | Largest customer | — |
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Segment revenue (INR Cr) | 86 | 135.3 | 239.6 |
Segment PBT (INR Cr) | 3 | 32.6 | 28.0 |
Segment PBT margin (%) | 3.5 | 24.1 | 11.7 |
YoY revenue growth (%) | 41 | 57 | 77 |
Contribution to total revenue (%) | 100 | 100 | 100 |
Revenue by Segment
| Metric | FY2025 | FY2026 |
|---|---|---|
Consolidated revenue (INR Cr) | 135.3 | 239.6 |
Amal standalone revenue (INR Cr) | 48.9 | 84.9 |
Implied ASCL revenue before eliminations (INR Cr) | 86.4 | 154.7 |
Amal standalone PBT (INR Cr) | 9.4 | 6.3 |
Implied ASCL PBT (INR Cr) | 23.2 | 21.6 |
Amal standalone PAT (INR Cr) | 6.9 | 4.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (%)
| Metric | FY2026 |
|---|---|
Sulphur-based products share of revenue (%) | 84 |
Steam share of revenue (%) | 16 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 43 | 61 | 86 | 135.3 | 239.6 |
Total expenses excl. D&A and interest (INR Cr) | 40 | 67 | 71 | 91.6 | 203.9 |
EBITDA / PBILDT excl. other income (INR Cr) | 4 | -6 | 15 | 43.7 | 35.7 |
Other income (INR Cr) | 0 | 1 | 0 | 0.5 | 2.2 |
Depreciation (INR Cr) | 2 | 7 | 9 | 9.2 | 9.3 |
EBIT incl. other income (INR Cr) | 3 | -12 | 7 | 34.6 | 28.6 |
Interest (INR Cr) | 1 | 4 | 4 | 2.0 | 0.7 |
Profit before tax (INR Cr) | 2 | -16 | 3 | 32.6 | 28.0 |
Tax (INR Cr) | 1 | 0 | 1 | 3.3 | 5.6 |
Net profit (INR Cr) | 1 | -16 | 2 | 29.3 | 22.4 |
EPS basic (INR) | 0.90 | -13.03 | 1.38 | 23.69 | 18.10 |
EPS diluted (INR) | 0.90 | -13.03 | 1.38 | 23.69 | 18.10 |
Dividend per share (INR) | 0 | 0 | 0 | 1.0 | 1.5 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EBITDA margin (%) | 9.3 | -9.8 | 17.4 | 32.3 | 14.9 |
EBIT margin (%) | 7.0 | -19.7 | 8.1 | 25.6 | 11.9 |
PBT margin (%) | 4.7 | -26.2 | 3.5 | 24.1 | 11.7 |
Net margin (%) | 2.3 | -26.2 | 2.3 | 21.7 | 9.3 |
Revenue growth YoY (%) | 43 | 42 | 41 | 57 | 77 |
Effective tax rate (%) | 31 | 3 | 39 | 10 | 20 |
Income Statement and Margin Analysis (%)
| Metric | Q1FY2026 | Q2FY2026 | Q3FY2026 | Q4FY2026 | Q1FY2027 | Q2FY2027 |
|---|---|---|---|---|---|---|
Revenue (INR Cr) | 47.31 | 54.00 | 62.59 | 75.74 | 96.54 | 131.23 |
Operating profit (INR Cr) | 11.63 | 8.60 | 8.09 | 7.35 | 17.09 | 8.47 |
OPM (%) | 24.58 | 15.93 | 12.93 | 9.70 | 17.70 | 6.45 |
Other income (INR Cr) | 0.44 | 0.47 | 0.59 | 0.74 | 6.13 | 2.15 |
PBT (INR Cr) | 9.59 | 6.63 | 6.13 | 5.60 | 20.87 | 8.18 |
Net profit (INR Cr) | 9.40 | 6.06 | 5.02 | 1.90 | 16.73 | 6.16 |
EPS (INR) | 7.60 | 4.90 | 4.06 | 1.54 | 13.53 | 4.98 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 100 | 118 | 106 | 122 | 154 |
Net fixed assets (INR Cr) | 14 | 90 | 86 | 80 | 77 |
Capital work-in-progress (INR Cr) | 66 | 1 | 1 | 0 | 3 |
Investments (INR Cr) | 0 | 0 | 1 | 20 | 37 |
Other assets incl. cash, receivables, inventory (INR Cr) | 19 | 27 | 19 | 21 | 38 |
Total borrowings (INR Cr) | 51 | 35 | 24 | 0 | 0 |
Other liabilities (INR Cr) | 14 | 15 | 13 | 22 | 34 |
Shareholders' equity (INR Cr) | 35 | 68 | 70 | 99 | 120 |
Equity share capital (INR Cr) | 9.43 | 12.36 | 12.36 | 12.36 | 12.36 |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operations (INR Cr) | -1 | -10 | 21 | 50 | 22 |
Cash from investing (INR Cr) | -43 | -16 | -9 | -22 | -22 |
Cash from financing (INR Cr) | 44 | 29 | -14 | -25 | -1 |
Capex derived (INR Cr) | 63 | 16 | 8 | 4 | 7 |
Free cash flow (INR Cr) | -64 | -26 | 13 | 46 | 15 |
Dividends paid derived (INR Cr) | 0 | 0 | 0 | 0 | 1.2 |
Share buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
CFO to EBITDA (%) | -105 | 172 | 144 | 119 | 68 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE computed (%) | 2.5 | -31.1 | 2.5 | 34.7 | 20.4 |
ROA computed (%) | 1.1 | -14.7 | 1.5 | 25.7 | 16.2 |
ROCE Screener (%) | 4 | -12 | 7 | 36 | 26 |
Debt to equity (x) | 1.46 | 0.51 | 0.34 | 0 | 0 |
Interest coverage EBITDA to interest (x) | 4.0 | -1.5 | 3.8 | 21.5 | 54.6 |
Asset turnover computed (x) | 0.58 | 0.56 | 0.77 | 1.19 | 1.74 |
Debtor days | 11 | 25 | 23 | 27 | 30 |
Inventory days | 34 | 26 | 28 | 33 | 25 |
Payable days | 42 | 31 | 36 | 68 | 38 |
Cash conversion cycle (days) | 4 | 21 | 15 | -9 | 17 |
Revenue by Region and Revenue by Region (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Total revenue (INR Cr) | 135.3 | 239.6 |
Revenue from Atul derived (INR Cr) | 47.4 | 91.0 |
Revenue from other customers derived (INR Cr) | 87.9 | 148.6 |
Atul share of revenue (%) | 35 | 38 |
Capital Markets
| Metric | 1 year | 3 years | 5 years | 10 years |
|---|---|---|---|---|
Stock price return or CAGR (%) | 2 | 28 | 15 | 28 |
Share Price History
| Date | Price (INR) | Market cap (INR Cr) | Source |
|---|---|---|---|
22 Jan 2025 | 711 | 923 | INDmoney |
19 Dec 2025 | 686.90 | — | ICICIdirect |
2 Feb 2026 | 462.50 | — | Emkay |
21 Apr 2026 | 653 | 809 | Kotak Neo |
9 Jun 2026 | 541.05 | 672 | Value Research |
17 Jul 2026 | 752.15 (upper circuit) | — | JM Financial |
14 Aug 2026 | 750 | — | ICICIdirect |
16 Oct 2026 | 746 (−20% on the day) | 923 | Screener |
Valuation Multiples
| Multiple | Amal | Peer reference |
|---|---|---|
P/E (TTM) | 31.0x (Screener) | Peer median 28.68x (Value Research, 9 Jun 2026) |
P/B | 6.5x (₹746 / BV ₹114) | Peer median 2.90x (Value Research, 9 Jun 2026) |
Market cap / Sales (TTM) | About 2.5x (₹923 cr / ₹366 cr) | — |
EV / Sales (indicative) | About 2.4x, using ₹37 cr investments as a cash proxy | — |
EV / EBITDA (indicative) | About 21.6x on TTM EBITDA of about ₹41 cr. Upstox showed 18.1x in May 2026. | — |
Dividend yield | About 0.20% | — |
Per-Share Data and Returns & Leverage Ratios (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 0 | 0 | 0 | 1.0 | 1.5 |
Dividend payout ratio (%) | 0 | 0 | 0 | 4 | 8 |
Analyst Conclusions
Management guidance. No formal guidance. The only forward-looking statements are about capex: the SO2 expansion within about two years, plus the steam pipeline and sulphur storage, about ₹25 cr in total funded internally. CARE's outlook expects strong FY2027 revenue growth from higher realisations and continued healthy utilisation. It expects profitability to stay broadly stable but capped by high sulphur prices and limited pass-through.
Consensus expectations. None (no coverage). Implied run-rate: H1 FY2027 revenue of ₹228 cr points to FY2027 revenue that could exceed ₹400 cr if sulphur-linked prices stay high. This is an analyst extrapolation, not guidance. Profit trajectory is highly uncertain.
Bull case
-
Spread normalisation. Amal earned a 32% EBITDA margin and ₹29 cr PAT in FY2025 at US$157/MT sulphur. If sulphur retreats from about US$1,050/MT, the much larger revenue base and a debt-free balance sheet could produce record absolute profits.
-
Self-funded growth with high returns. About ₹25 cr of capex (SO2 +60 TPD, steam pipeline, storage) against a ₹141 cr equity base. Existing SO2 capacity is almost fully used, so incremental returns should be high.
-
Embedded optionality from Atul. Any further Atul capacity growth (FY2026 revenue +13%) drives captive acid and steam demand. CARE names higher Atul offtake as a positive rating trigger, which hints at further dedicated capacity.
Bear case
-
Margin trap. Q2 FY2027 OPM of 6.45% on record revenue shows that pass-through fails when sulphur spikes. At about 31x TTM earnings, which include a one-off ₹5.61 cr incentive, the valuation leaves little room if margins stay in single digits.
-
Captive economics cap upside. About 38% of revenue goes to the controlling shareholder on undisclosed terms. Minority holders depend on the fairness of related-party pricing, and the parent has little incentive to let Amal capture windfall spreads.
-
Regional supply wave. Large smelter-acid additions in Gujarat (Adani about 1.5 million t/a; GSFC Sikka about 0.6 million t/a) could depress merchant acid prices just as input costs are high.
Key catalysts and things to monitor over the next 12 months
-
International sulphur prices (Middle East FOB and India CFR) and their trajectory from about US$1,050/MT.
-
Q3 FY2027 results (expected Jan 2027): whether OPM recovers from 6.45%.
-
Progress on SO2 expansion, the steam pipeline and the sulphur storage facility.
-
Atul's capacity additions and offtake commitments; related-party transaction disclosures in AR FY2026-27.
-
The rise in working capital (receivables at higher prices) and whether non-fund-based limit usage moves to borrowing.
-
Commissioning and ramp-up of new Gujarat acid supply.
-
Any change in the group structure (consolidation into Atul).
-
Annual planned shutdown timing (typically Q1).
Concluding analyst verdict. Amal Ltd has been rebuilt from a BIFR-era failure into a compact, well-run sulphur-chemicals utility for the Atul group. The rebuild worked: in five years revenue rose from ₹30 cr to ₹240 cr, the balance sheet went from 1.5x debt/equity to net cash, and in FY2025 the company showed that a 440 TPD sulphur-burning complex with steam integration can earn 30%+ EBITDA margins and returns on equity above 30%. The asset base is fully used, parent support is explicit and rated (CARE A+, notched up from Atul's AA+), and management has resumed modest growth capex funded from internal cash.
The investment problem is that Amal's earnings are a function of one variable it does not control: the spread between sulphur and the acid, derivatives and steam it sells. That spread has been squeezed hard. Sulphur moved from about US$157/MT to about US$1,050/MT over roughly eighteen months, and operating margin fell from 32% (FY2025) to 15% (FY2026) and then to 6.5% (Q2 FY2027). Reported headline growth of +77% and +143% overstates the business's health, because it mostly reflects price inflation on roughly flat volumes. Recent profit has also been flattered by one-offs and inventory gains. At about 31x trailing earnings and 6.5x book, the market is pricing a recovery in spreads, not the current run-rate.
On balance, Amal is a sound credit and a strategically secure business but a speculative equity. The decisive things to watch are the direction of sulphur prices and evidence, in the second half of FY2027, that contract pass-through with Atul and merchant customers is resetting. Without both, valuation risk outweighs operating quality.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure on Amal board | Background and other roles | Classification |
|---|---|---|---|---|
Sunil Siddharth Lalbhai | Chairman | Since 2010 (MCA: 24 Sep 2010) | Chairman (since 2007) and Managing Director (since 1984) of Atul Ltd; Chairman of Atul Bioscience; Vice Chairman of Atul Rajasthan Date Palms (Atul website). AR FY2023-24 refers to a postgraduate degree in Chemistry. Holds about 0.41% of Amal (Simply Wall St). | Non-executive, promoter |
Rajeev Kumar | Managing Director | Since 24 Mar 2017; reappointed at the 52nd AGM, 14 Aug 2026 | President of Atul Ltd. Age about 53 (Simply Wall St). Holds about 0.07%. | Executive |
T R Gopi Kannan (Gopi Kannan Rengachari Thirukonda) | Director | — | Whole-time Director and CFO of Atul Ltd (Atul board archive) | Non-executive (Atul nominee) |
Jyotin Kantilal Mehta | Director | Since 2022; reappointed 14 Aug 2026 | — | Independent, non-executive |
Dipali Chirag Sheth | Director | — | — | — |
Mahalakshmi Subramanian | Director | — | — | — |
Venkatraman Srinivasan | Director | — | — | — |
Drushti Rahul Desai | Director | — | — | — |
Executive Leadership Team
| Name | Title | Notes |
|---|---|---|
Rajeev Kumar | Managing Director | See above |
Yogesh Vyas | Chief Financial Officer | — |
Ankit Mankodi | Company Secretary & Compliance Officer | Per BFSL/Nirmal Bang data. Simply Wall St shows the CS role held for about 10.6 years, which may refer to a predecessor. |
M G Palekar | Listed among management | — |
Directors' Remuneration
| Person | Salary (INR Mn) | Bonus (INR Mn) | Stock (INR Mn) | Total (INR Mn) | Year |
|---|---|---|---|---|---|
Rajeev Kumar, MD | 1.9 | 0 | 0 | 1.9 | FY2025 |
Shareholding Trend
| Holder category | Mar 2017 | Mar 2018 | Mar 2023 | Mar 2025 | Sep 2026 |
|---|---|---|---|---|---|
Promoters & promoter group (%) | 53.73 | 65.51 | 71.33 | 71.34 | 71.35 |
Domestic institutions (%) | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 |
Public (%) | 46.24 | 34.47 | 28.66 | 28.64 | 28.61 |
Major Shareholders
| Holder | Stake | Notes |
|---|---|---|
Atul Ltd, mainly through Atul Finserv Ltd | 49.86% | CARE (2023–2026) |
Other promoter group entities (Lalbhai group investment companies, e.g. Aayojan Resources, Adhinami Investments, Aagam Agencies, Akshita Holdings, Anusandhan Investments) | About 21.5% in aggregate (71.35% minus 49.86%) | — |
Sunil Lalbhai | About 0.41% | Simply Wall St |
Rajeev Kumar | About 0.07% | Simply Wall St |
Mutual funds (3 schemes) | 0.01% | Trendlyne |
Competitive Landscape
Key Competitors
| # | Company | Route / relevance to Amal | Notes |
|---|---|---|---|
| 1 | Kutch Copper (Adani group), Mundra, Gujarat | Smelter acid; new copper smelter in Gujarat expected to add about 1.5 million t/a of acid (CRU) | Largest new regional supply source; can pressure Gujarat merchant acid prices |
| 2 | Hindalco Industries (Birla Copper, Dahej, Gujarat) | Smelter acid | Large merchant seller in Gujarat |
| 3 | Hindustan Zinc (Vedanta group) | Smelter acid (zinc/lead) | Mainly Rajasthan; national supply |
| 4 | Vedanta / Sterlite Copper (Thoothukudi) | Smelter acid; plant has over 1.2 million t/a acid capacity (Bonafide) but has been shut since 2018 | Possible restart is a supply risk |
| 5 | IFFCO (Paradeep) | Sulphur-burning, captive for phosphates; about 2.31 million t/a acid capacity (Bonafide) | Mostly captive |
| 6 | Gujarat State Fertilizers & Chemicals (GSFC), Sikka unit | New sulphur-burning acid plant of about 600,000 t/a commissioning 2025–26 (CRU) | Gujarat capacity addition |
| 7 | Coromandel International | Sulphur-burning, captive for fertilisers | Expanding sulphur-based capacity |
| 8 | Paradeep Phosphates | Sulphur-burning, captive | Fertiliser-integrated |
| 9 | Small Ankleshwar/Vapi/Dahej merchant sulphur burners (unlisted) | Direct merchant competitors in the South Gujarat chemical belt | Names and sizes not publicly disclosed |
| 10 | Imported smelter acid (Japan, Korea and others) | Imports into Indian ports; India imported about 1.8–1.9 million tonnes in 2020 (Research & Markets) | Sets coastal price ceilings |
Peer Comparison FY2026
| Metric | Amal Ltd (FY2026) | Atul Ltd (FY2026, parent/customer) |
|---|---|---|
Revenue | ₹239.6 cr | ₹6,317 cr consolidated (CARE) |
Revenue growth | 77% | 13% (₹5,584 cr to ₹6,317 cr, CARE) |
EBITDA margin | 14.9% | 17.06% (CARE) |
Net debt | Net cash | Group largely debt-free (Atul AGM 2026) |
Recent Developments
Routine compliance filings are included where they add timeline context.



